Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cordance Medical
Cordance Medical

Cordance Medical

Seed

Cordance Medical: Innovating radical CNS pathology treatments through Rave therapy.

HQ
Mountain View, CA, US
Founded
2018
Overview
Compare
Fundraising
Employees

Founded with the mission to revolutionize treatments for central nervous system (CNS) pathologies, Cordance Medical focuses on developing innovative therapies, including their pioneering Rave therapy. The company aims to address critical healthcare challenges such as brain cancers, Alzheimer's, and Parkinson's disease. Their flagship product, the NeuroAccess system, is designed to improve patient outcomes by effectively navigating the blood-brain barrier.

Cordance Medical has garnered significant attention, notably receiving the FDA's Breakthrough Device Designation for their NeuroAccess system. The company is supported by a team of experts in neurology and medical technology, and has attracted investment from leading venture capital firms specializing in healthcare innovation. Cordance Medical's advancements have the potential to significantly impact the treatment landscape for CNS diseases, offering new hope to patients worldwide.

Cordance Medical - Similar Companies

Jan Medical logo

Jan Medical

janmedical.com

Cerevance logo

Cerevance

cerevance.com

Neurolink logo

Neurolink

Traverse Vascular logo

Traverse Vascular

Renata Medical logo

Renata Medical

renatamedical.com

Link Medicine logo

Link Medicine

linksciences.com

Q'Apel Medical logo

Q'Apel Medical

qapelmedical.com

MindRhythm logo

MindRhythm

mindrhythm.com

Niche Biomedical logo

Niche Biomedical

Providence Medical Technology logo

Providence Medical Technology

providencemt.com

Cormedics logo

Cormedics

cormedicscorp.com

Neuro42 logo

Neuro42

4C Medical Technologies logo

4C Medical Technologies

4cmed.com

FastWave Medical logo

FastWave Medical

CraniUS logo

CraniUS

craniusmed.com

Cordance Medical - Quick Facts

Who are Cordance Medical's competitors?

Companies similar to Cordance Medical include Jan Medical, Cerevance, Neurolink and Traverse Vascular.

When was Cordance Medical founded?

Cordance Medical was founded in 2018.

Where is Cordance Medical's headquarters located?

Cordance Medical's headquarters is located in Mountain View, CA, US.

How much has Cordance Medical raised to-date?

As of Aug 1, 2022, Cordance Medical has raised a total of $1.2M (USD).

How many employees does Cordance Medical have?

Cordance Medical has 13 employees as of Feb 4, 2024.

Cordance Medical - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified